ISCP Newsletter – December 2017

---

This has been an eventful year for ISCP with a new website up and running, a new journal and a very successful Annual Scientific Meeting. The meeting report of the 22nd Annual Scientific Meeting is available on the ISCP website as well as videos of the featured sessions and expert opinions.

At the end of 2017 Antoni Martinez-Rubio will pass the presidency to Koji Hasegawa who will take over as President in 2018. Prof Hasegawa is also the chairperson for the Host Organising Committee for the 23rd ISCP Annual Scientific Meeting which will be held on the 26th and 27th of May, 2018 at the Ritz-Carlton in Kyoto. The programme chairs are Masayuki Yoshida and Masataka Sata.

Please forward any news or information on upcoming conferences or meetings that you would like included in the next Newsletter (March 2018) to me at lisa.demos@monash.edu by the 22nd of February, 2018.

Wishing everyone the best for the festive season and 2018.
Editors: John McNeil & Lisa Demos

---

President’s section

Dear Colleagues,

During 2017, we have achieved several positive steps including; the consolidation of our relationship with the European Cardiology Review (ECR) which has received Pubmed citation, a new website, the position paper on Antiarrhythmic Drugs which will be published probably in December/January, integration of some new and active governors, the Annual Scientific Meeting held in Barcelona which had a great high level programme and which allowed delegates to enjoy the Catalan city and culture, and continued collaboration with other societies.

I would like therefore to express again my gratitude to all of you who have collaborated in any way with the ISCP. Surely, without help from so many of you, it would have been impossible to achieve these goals. At the same time, I would like to encourage all of us again to further promote the society. I believe this is the best way to assist the ISCP Board with the growth and success of the society.

I want to thank all the ISCP Board Members, who collaborated in diverse working groups and did a great job for the ISCP during 2017. Of those who contributed, Prof Juan Carlos Kaski mainly worked in the consolidation of ECR and the website. Prof Felipe Martinez represented the society in diverse international specialised forums, Prof George Dan organised meetings and carried out the titanic task of coordinating the position paper on Antiarrhythmic Drugs with other societies (European Heart Rhythm Association (EHRA), ESC Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS) ), Prof Augusto Gallino continued in the role of ISCP Treasurer a position he has held for the past four years, Prof Thomas Kahan took as his main role the coordination of governors and Prof Dennis Cokkinos and Prof Edgardo Escobar mainly worked as Secretary and Advisor, respectively. Prof Koji Hasegawa has been a very supportive vice president and has already organised the next annual congress while also helping to expand the society in the Asiatic countries.

I also would like to thank our secretary Begoña Lugg as well as Dr Lisa Demos and Prof John McNeil for their essential and dependable support over the year and also those Governors who have contributed to the ISCP growth and visibility. Also several members (e.g. Prof Juan Tamargo and Prof Pablo Avanzas, the scientific collaborators of the website) have successfully contributed to the society. I want to thank them and all those who in any way have supported us over the year.

As an international, intercontinental society, the future of the ISCP looks brilliant. I hope you will join us and participate in our educational and research endeavours and I especially hope that many of you will be able to join us at our next Annual Meeting in Kyoto, Japan in May 2018 for what we are sure will be an inspiring and memorable 23rd Annual Scientific Meeting of the Society. In addition, it will give us an opportunity to enjoy the rich ancient Japanese culture and share time together.

Dear friends, in summary, it has been a privilege for me to serve the ISCP. Now, you all know where you have a friend if you need me.

Receive my warmest wishes for the next days and for the New Year!

Prof Antoni Martinez-Rubio,
President, ISCP

---

23rd Annual Scientific Meeting of ISCP- Kyoto 2018

We invite you to join us for scientific exchange on current topics in evidence-based clinical management and eagerly look forward to your active participation in the 2018 Kyoto ISCP meeting. We are certain that you will enjoy the most up-to-date scientific program, entertaining social and cultural events, and the unique atmosphere of historic Kyoto.

Topics include:

• Prevention of Atherosclerosis Targeting Lipid Metabolism and Inflammation
• Pharmacotherapy and Life-style Modification for Heart Failure: the Present and the Future
• Cardiovascular Imaging Guiding Pharmacotherapy
• Controversies in Anti-coagulant Therapy in Atrial Fibrillation and Deep Vein Thrombosis
• Treatment of Atrial Fibrillation: the Place of Antiarrhythmic Drugs
• Drug Management of Coronary Vasospasm, Microvascular Angina and Takotsubo Cardiomyopathy
• Anti-thrombotic Therapy during and after Coronary Intervention
• Meet the Experts ― Pharmacotherapy Challenges
• WHO/ISCP Joint Plenary Session – Global Cardiovascular Risk Management to Achieve ‘25 by 25’
• Joint Panel Discussion with ESC Working Group on Cardiovascular Pharmacotherapy
• Joint session with International Society of Cardiomyopathy, Myocarditis and Heart Failure
• Joint Workshop with Asian Pacific Society of Cardiology
• Joint Symposium with Asian Pacific Society of Cardiology
• Henry N. Neufeld Memorial Award Lecture

Koji Hasegawa
President-Elect ISCP
Chair, 23rd Annual Scientific meeting of ISCP 2018 Kyoto
National Hospital Organization, Kyoto Medical Center

---

ISCP Book Series: Current Cardiovascular Therapy

The Current Cardiovascular Therapy Series created with the support of the ISCP is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action, the possible adverse effects, and the management of patients prescribed these drugs. The emphasis is on current practice, but with an eye to the near-future direction of treatment.

The series is published by Springer currently includes 9 books which are available as e-books or in soft cover at a discounted rate for ISCP members.

---

European Cardiology Review (ECR) – Official ISCP Journal

The European Cardiology Review is a peer-reviewed bi-annual journal comprising review articles, editorials and case reports. It features balanced and comprehensive articles written by leading authorities, addressing the most important and salient developments in cardiovascular medicine and practice.

The journal is led by Editor-in-Chief Juan Carlos Kaski, supported by Associate Editors, and underpinned by an editorial board of world-renowned physicians, ECR is comprised of peer-reviewed articles that aim to provide timely updates on the most pertinent cardiology issues.

The ECR is a free on-line review which can be accessed via the website.

---

ISCP News

72nd Brazilian Congress of Cardiology, Sao Paulo

This was held from 3 to 4 November and had 8026 registered delegates. Most were cardiologists (the society comprises 14,000 members) who had the opportunity to hear updates in the various areas of our specialty. There was a special session called International Activity: Ibero-Latin American Symposium – Promotion in Health and Prevention of Cardiovascular Diseases which had strong participation of ISCP.

The schedule was as follows:

• President: Celso Amodeo (Communication Director and Member appointed to the ISCP board).
• Lecturer: Alberto Lorenzatti (ISCP – Argentina) – Current perspectives of PCSK-9 Inhibitors in cardiovascular prevention
• Lecturer: Felipe Martinez (ISCP-Argentina): New insights on the blockade of the renin-angiotensin-aldosterone system (RAAS) and other systems.
• Lecturer: Joaquim Serra (FAC-Argentina) – Goals and medical therapies for hypertension in the current era: recognizing morbidities and risk profile of patients
• Celso Amodeo had the opportunity to present on the ISCP, and Prof Valentin Fuster (USA) presented Scientific Bases of health promotion: future directions at the closing of the conference.

LIV Chilean Society of Cardiology Congress, Santiago

Edgardo Escobar presented the Opening Lecture “From basic and clinical research to the Digital era” on 30th November.

New Appointments

We welcome new ISCP Governors for 2018: Prof Baek who has accepted to be the ISCP Governor for Korea, Jack Tan Governor representing Singapore and Nanette Rey for the Philippines.

Pablo Avanzas has been appointed as Special Scientific Advisor with special responsibility for assisting the ISCP Secretary.

New content on the ISCP website

Remember to check the webinars and conference talks in the e-learning section of the website and the Expert Reviews and Expert Opinions sections. From next year these sections will be available only to Full and Junior Members. If this means you will no longer have access, do take a look now – we feel that these two sections should be of great interest and are one of the benefits of Full Membership.

Membership

ISCP welcomes applications for membership from individuals with an interest in cardiovascular drug treatment. Those working in the medical field (clinical, research and industry), basic scientists, pharmacologists, pharmacists, nurses, biomedical science students, and others, interested in exchanging ideas for improving cardiovascular pharmacotherapy and establishing new, more effective modalities for drug treatment of cardiovascular conditions. To join or renew your membership go to: https://www.iscpcardio.org/register/ Please note free membership is available to those who register by the end of 2017.

---

News from World Heart Federation (WHF)

Emerging Leaders new website: The Emerging Leaders Programme was created by WHF in 2014 to develop a cadre of experts who collaborate, research and act to reduce premature mortality from cardiovascular disease globally in line with ’25by25′. The new website has been relaunched within the WHF main website, so there are more opportunities to develop useful functionality and to align Emerging Leaders more closely with the work of WHF.

WHF completes the Children in the City pilot project: this pilot encouraged children living in urban areas to be more active and keep a healthy heart.

Consultation on 13th WHO General Programme of Work: WHO published its draft 13th General Programme of Work (GPW13), which was open for consultation until Wednesday 15th November.

Montevideo Roadmap 2018-2030: During October, WHF attended the WHO Global Conference on NCDs in Montevideo, Uruguay. The focus of the conference was on supporting the achievement of the Sustainable Development Goal target 3.4 to reduce premature deaths from NCDs by one-third by 2030 through prevention and treatment. The Heads of State and Government ministers from around the world endorsed the ‘Montevideo Roadmap 2018-2030 on NCDs as a Sustainable Development Priority’.

Global Coalition for Circulatory Health: The Coalition unites international, regional and national stakeholders in CVD to drive the urgent action needed to combat heart disease and stroke, in preparation for the third UN High-level Meeting on NCDs in 2018.

WHF and RHD: for the latest updates including history, current position and looking ahead to 2018 and beyond.

---

Recent and Upcoming Meetings, Courses and Workshops